Cellectar Biosciences, Inc. (CLRB)
NASDAQ: CLRB · Real-Time Price · USD
0.3083
+0.0055 (1.82%)
Apr 23, 2025, 4:00 PM EDT - Market closed
Cellectar Biosciences Analyst Ratings
Total Analysts
1
Consensus Rating
Hold
Price Target
n/a
Upside
n/a
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Dec 11, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $14 → $12 | Buy | Maintains | $14 → $12 | +3,792.31% | Nov 19, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $14 | Buy | Reiterates | $14 | +4,441.03% | Oct 11, 2024 |
| Roth MKM | Roth MKM | Strong Buy Maintains $20 → $28 | Strong Buy | Maintains | $20 → $28 | +8,982.06% | Mar 28, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $11 → $12 | Buy | Reiterates | $11 → $12 | +3,792.31% | Mar 28, 2024 |
| Roth MKM | Roth MKM | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +6,387.19% | Mar 4, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $3 → $4 | Strong Buy | Maintains | $3 → $4 | +1,197.44% | Nov 4, 2022 |
| Oppenheimer | Oppenheimer | Buy Initiates $55 | Buy | Initiates | $55 | +17,739.77% | Jul 18, 2022 |
| Oppenheimer | Oppenheimer | Buy Initiates $50 | Buy | Initiates | $50 | +16,117.97% | Jul 1, 2020 |
| Maxim Group | Maxim Group | Strong Buy Initiates $30 | Strong Buy | Initiates | $30 | +9,630.78% | Jun 23, 2020 |
| Roth Capital | Roth Capital | Strong Buy Initiates $100 | Strong Buy | Initiates | $100 | +32,335.94% | Jan 21, 2020 |
| Roth Capital | Roth Capital | Strong Buy Initiates $110 | Strong Buy | Initiates | $110 | +35,579.53% | Sep 13, 2019 |
| Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy Initiates $270 | Strong Buy | Initiates | $270 | +87,477.04% | Dec 21, 2016 |